Research Topics
| F De VriesSummaryAffiliation: Utrecht University Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort studyArief Lalmohamed
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Stroke 43:3225-9. 2012..However, timing of stroke in THR patients compared with matched controls and influence of drug use remain unknown. The objective of this study was to determine timing of stroke in patients with THR compared with matched control subjects...
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosisMarloes T Bazelier
Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands
Neurology 79:922-8. 2012..To derive a simple score for estimating the long-term risk of osteoporotic and hip fracture in individual patients with MS...- Knee arthroplasty and risk of hip fracture: a population-based, case-control studyArief Lalmohamed
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Calcif Tissue Int 90:144-50. 2012..We found that KAs are associated with a 54% increased risk of hip fracture, in particular among adult patients aged <71 years old. Fracture risk assessment could be considered in patients who are about to undergo a KA... - Use of beta2 agonists and risk of acute myocardial infarction in patients with hypertensionFrank De Vries
Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Pharmacotherapy, Universiteit Utrecht, Utrecht, The Netherlands
Br J Clin Pharmacol 65:580-6. 2008.... - Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonatesF De Vries
Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, The Netherlands
Osteoporos Int 20:1989-98. 2009..Positive associations were observed for any hip and vertebral fracture. The effect size was modest; however, the significance lies in the widespread prescribing of acid suppressants... - Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The NetherlandsF De Vries
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Universiteit Utrecht, Sorbonnelaan 16, 3584 CA Utrecht, The Netherlands
Calcif Tissue Int 80:69-75. 2007.... - Antipsychotic use and the risk of hip/femur fracture: a population-based case-control studyS Pouwels
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Osteoporos Int 20:1499-506. 2009..Furthermore, no evidence for a dose effect was found... - Use of anti-depressants and the risk of fracture of the hip or femurM W M van den Brand
Department of Geriatric Medicine, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands
Osteoporos Int 20:1705-13. 2009..This should be considered when prescribing anti-depressants to patients... 
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control studyF De Vries
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
J Intern Med 261:170-7. 2007..Patients using higher dosages of inhaled or oral glucocorticoids (GCs) have an increased risk of hip/femur fractures. The role of the underlying disease in the aetiology of this increased risk has not been widely studied...- Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort studyA Lalmohamed
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Eur J Neurol 19:1007-14. 2012..Multiple sclerosis (MS) has been associated with increased mortality rates. However, influence of lifestyle parameters remains unknown, and inconsistencies exist regarding findings for causes of death... - Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control studyM E L Arbouw
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Universiteit Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
Osteoporos Int 22:2197-204. 2011..Concomitant use of antidepressants further increased this risk. Fracture risk assessment may be warranted in elderly users of dopaminergic drugs... - Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control studyS Pouwels
Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, P O BOX 80082, 3508 TB, Utrecht, The Netherlands
Osteoporos Int 22:903-10. 2011..Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causal relationship between PPI use and hip fracture risk... - Fracture rate in patients with myasthenia gravis: the general practice research databaseS Pouwels
Utrecht Institute for Pharmaceutical Sciences, Universiteit Utrecht, Utrecht, The Netherlands
Osteoporos Int 24:467-76. 2013..Overall fracture risk is not statistically increased compared with age- and gender-matched controls irrespective of glucocorticoid use, but was increased in those using antidepressants, anxiolytics or anticonvulsants... - Risk of fractures in patients with multiple sclerosis: a population-based cohort studyM T Bazelier
Utrecht Institute for Pharmaceutical Sciences, Utrecht University, The Netherlands
Neurology 78:1967-73. 2012..To examine the risk of fracture in patients with multiple sclerosis (MS) compared with population-based controls... - Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fracturesA Lalmohamed
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands
Osteoporos Int 23:861-9. 2012..The FRAX tool has been calibrated to the entire Dutch population, using nationwide (hip) fracture incidence rates and mortality statistics from the Netherlands. Data used for the Dutch model are described in this paper... - Severity of obstructive airway disease and risk of osteoporotic fractureF De Vries
Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, The Netherlands
Eur Respir J 25:879-84. 2005..However, adequate adjustment for disease severity is essential when the association between the use of inhaled corticosteroids and risk of osteoporotic fracture is studied in observational research... - Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United StatesT P Khong
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences UIPS, Utrecht University, Universiteitsweg 99, Utrecht, The Netherlands
Calcif Tissue Int 91:24-31. 2012..8 % and 8.2 %. During the next phase of the IMI-PROTECT study, a comparison with individual patient data will show whether this approach is valid...